Relationship of dehydroepiandrosterone and cortisol in disease

Medical Hypotheses

Volumn 49, Issue 1, 1997, Pages 85-91

  Hechter, O ^a   Grossman, A ^b   Chatterton Jr , R T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; GLUCOCORTICOID; HYDROCORTISONE; PRASTERONE SULFATE; PREDNISONE;

ADOLESCENT; ADRENAL HYPERPLASIA; ADULT; AGING; CHRONIC DISEASE; CIRCADIAN RHYTHM; CORTICOSTEROID THERAPY; CUSHING DISEASE; DRUG INDUCED DISEASE; ENDOCRINE DISEASE; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PATHOGENESIS; POLYARTHRITIS; PRIORITY JOURNAL; REVIEW; STEROIDOGENESIS;

EID: 0030921207     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(97)90258-9     Document Type: Article

References (41)

1. Orth D N, Kovacs W J, Debold C R. The adrenal cortex. In: Wilson J D, Foster V W, eds. Williams Textbook of Endocrinology, 8th edn, Philadelphia: WB Saunders, 1992: 489-1188.
2. Orentreich N, Brind J L, Rizer R L, Vogelman J H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations from puberty through adulthood. J Clin Endocrinol Metab 1984; 59: 551-555.
3. Lupien S, Lecours A R, Lassier I, Schwartz G, Nair H P V, Meany M J. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 1994; 14: 2893-2903.
4. Kalimi M, Regelson W, eds. The Biologic Role of Dehydroepiandrosterone. Berlin: Walter de Gruyter, 1990.
5. Gordon G B, Shantz L M, Talalay P. Modulation of growth, differentiation and carcinogenesis by DHEA. Adv Enz Reg 1990; 26: 355-382.
6. Parker L N. Adrenal Androgens in Clinical Medicine. San Diego: Academic Press, 1989.
7. Casson P K, Anderson N, Herrod H G, Yen S S C. Oral dehydroepiandrosterone in physiological doses modulates immune function in post menopausal women. Am J Obstet Gynecol 1993; 169: 1536-1546.
8. Whiteside T L, Herberman R B. The role of natural killer cells in human disease. J Clin Immunol Immunopath 1993; 53: 1-23.
9. Morales A J, Nolan A J, Nelson C, Yen S S C. Effect of replacement doses of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360-1367.
10. Svec F, Lopez-S A. Antiglucocorticoid actions of DHEA and low concentrations in Alzheimer's disease. Lancet 1989; 2: 1336.
11. Riley V, Fitzmaurice M A, Regelson W. DHEA and thymic integrity in the mouse. In: Kalimi M, Regelson W, eds. Biology of Dehydroepiandrosterone. Berlin: Walter de Gruyter, 1990: 131-145.
12. May M, Holmes E, Rogers W, Poth M. Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. Life Sciences 1990; 46: 1627-1630.
13. Blauer K L, Poth M, Rogers W, Bernton F W. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 1991; 129: 3174-3177.
14. Daynes R A, Dudley D J, Areneo B A. Regulation of murine lymphokine production in vivo. II: Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 1990; 20: 793-802.
15. Browne E C, Wright B E, Porter J R, Svec F. Dehydroepiandrosterone: antiglucocorticoid action in mice. Am J Med Sci 1992; 303: 366-374.
16. Wright B E, Porter J R, Browne E S, Svec F. Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats. Int J Obesity 1992; 16: 579-593.
17. Browne E B, Porter J K, Correa G, Abadie J, Svec F. Dehydroepiandrosterone regulation of the hepatic glucocorticoid receptor in the Zucker rat. J Steroid Biochem Molec Biol 1993; 45: 517-524.
18. Padgett D A, Loria R M. In vivo potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol and androstenetriol. J Immunol 1994; 153: 1544-1552.
19. Sapolsky R M, Krey L C, McEwen B S. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrin Rev 1986; 7: 284-298.
20. Compton M M, Cidlowsk L A. Identification of a glucocorticoid induced nuclease in thymocytes: a potential "lysis gene" product. J Biol Chem 1987: 262: 8288-8292.
21. Daynes R A, Araneo B A. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989; 19: 2319-2325.
22. Meikle A W, Dorchuck R W, Araneo B A et al. The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Molec Biol 1993; 42: 293-304.
23. Mossmann T R. Cytokine secretion phenotypes of TH cells: how many subsets, how much regulation? Res Immunol 1991; 1942: 9-13.
24. Fauci A S. Immunosuppressive and anti-inflammatory effects of glucocorticoids. In: Baxter J D, Rousseau G G, eds. Glucocorticoid Hormone Action. Berlin: Springer-Verlag, 1979: 449-466.
25. Suzuki T, Suzuki N, Daynes R A, Engelmann E G. Dehydroepiandrosterone enhances IL 2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 1991; 61: 202-211.
26. Kannan C R. Cushing's syndrome. In: The Adrenal Gland. New York and London: Plenum, 1988: 97-175.
27. Rotter J I, Wong F L, Lifrak E T, Parker L N. A genetic component to the variation of dehydroepiandrosterone sulfate. Metabolism 1985; 34: 731-736.
28. Sippel W G, Dorr H G, Bidlingmaier F, Knorr D. Plasma levels of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxy-progesterone, cortisol, and cortisone during infancy and childhood. Pediatr Res 1981; 14: 39-46.
29. de Peretti E, Forest M G. Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood. J Clin Endocrinol Metab 1978; 47: 572-579.
30. Chatterton R T Jr. Standard cortisol values in author's laboratory over a 10 yr period at Northwestern Memorial Hospital.
31. Meikle A W, Stringham J D, Wordham M G, Bishop D T. Hereitability of variation of plasma cortisol levels. Metabolism 1988; 37: 514-517.
32. Parker L N, Levin E R, Lifrak E T. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985; 60: 947-952.
33. Villette J M, Bourin P, Doinel C et al. Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab 1990; 70: 573-577.
34. Parker L N, Gral T, Perrigo V, Skowsky R. Decreased adrenal androgen sensitivity during aging. Metabolism 1981; 30: 601-603.
35. Pavlov E P, Barman S M, Chrousos G P et al. Responses of plasma adrenocorticotropin, cortisol and dehydrepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. J Clin Endocrinol Metab 1985; 62: 767-772.
36. Axelrod L. Glucocorticoid therapy. Medicine 1976; 55: 39-65.
37. Friedman M, Strang L B. Effect of long term corticosteroids and corticotrophin on the growth of children. Lancet 1966; ii: 291-292.
38. Underwood L E, Van Wyk J J. Normal and aberrant growth. In: Wilson J D, Foster V W, eds, Williams Textbook of Endocrinology, 8th edn. Philadelphia: W B Saunders, 1992: 1079-1138.
39. Carter M, James M T. Comparison of effects of corticotrophins and corticosteroids on pituitary-adrenal function. Ann Rheum Dis 1970; 29: 91-97.
40. vy) and normal mice. Endocrinol 1985; 117: 2279-2283.
41. Pashko L I, Schwartz A G. Antihyperglycemic effect of dehydroepiandrosterone analogue, 16α-fluoro-5-androsten-17-one. Diabetes 1993; 42: 1105-1107.